Alternations of Blood Pressure Following Surgical or Drug Therapy for Prolactinomas
Open Access
Abstract
Several subtypes of pituitary neuroendocrine tumors (PitNETs), such as acromegaly and Cushing’s disease, can result in hypertension. However, whether prolactinoma is associated with this complication remains unknown. Moreover, the effect of treatment with surgery or drugs on blood pressure (BP) is unknown. Herein, a retrospective study reviewed 162 patients with prolactinoma who underwent transsphenoidal surgery between January 2005 and December 2022. BP measurements were performed 1 day before and 5 days after surgery. Accordingly, patients’ medical characteristics were recorded. In addition, in situ rat and xenograft nude-mice prolactinoma models have been used to mimic prolactinoma. In vivo BP and serum prolactin (PRL) levels were measured after cabergoline (CAB) administration in both rats and mice. Our data suggest that surgery can effectively decrease BP in prolactinoma patients with or without hypertension. The BP-lowering effect was significantly associated with several variables, including age, sex, disease duration, tumor size, invasion, dopamine agonists (DAs)-resistance, recurrence, and preoperative PRL levels. Moreover, in situ and xenograft prolactinomas induced BP elevation, which was alleviated by CAB treatment without and with a statistical difference in rats and mice, respectively. Thus, surgery or CAB can decrease BP in prolactinoma, indicating that pre- and postoperative BP management becomes essential.Keywords
Funding Information
- National Natural Science Foundation of China (82141114, 81972339, 82201616, 20224Y0027)
- Clinical Research Fund from Shanghai Municipal Health Commission (82141114, 81972339, 82201616, 20224Y0027)
This publication has 36 references indexed in Scilit:
- Cabergoline for postpartum lactation suppression: Effect on blood pressure and pulseInternational Journal of Gynecology & Obstetrics, 2022
- Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomasPituitary, 2021
- The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatmentActa Neuropathologica, 2020
- Surgery for prolactinomas: a better choice?Pituitary, 2019
- Multidisciplinary team efforts improve the surgical outcomes of sellar region lesions during pregnancyEndocrine, 2019
- Long-term follow-up of female prolactinoma patients at child-bearing age after transsphenoidal surgeryEndocrine, 2018
- Diagnosis and Treatment of Pituitary AdenomasJAMA, 2017
- Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015JAMA, 2017
- Prolactin induces proliferation of vascular smooth muscle cells through a protein kinase C‐dependent mechanismJournal of Cellular Physiology, 1991
- Bromocriptine in the treatment of hypertensionEuropean Journal of Clinical Pharmacology, 1986